Publikationen
D90A-SOD1 ALS mimicking monoclonal gammopathy-associated ALS.
Synofzik M, Hagen JM, Biskup S, Schöls L. Amyotroph Lateral Scler. 2012 May;13(3):326-7. Epub 2012 Mar 13.
Characterizing POLG Ataxia: Clinics, Electrophysiology and Imaging.
Synofzik M, Srulijes K, Godau, J, Berg D, Schöls L. Cerebellum. 2012 Apr 12 [Epub ahead of print], DOI: 10.1007/s12311-012-0378-2
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.
Wachter B, Schürger S, Schmid A, Gröger A, Sadler R, Speidel A, Rolinger J, Pichler BJ, Berg D, Wagner HJ, von Ameln-Mayerhofer A, Küppers E. Behav Brain Res. 2012 Apr 10;232(1):148-158. [Epub ahead of print]
Impaired trunk stability in individuals at high risk for Parkinson's disease.
Maetzler W, Mancini M, Liepelt-Scarfone I, Müller K, Becker C, van Lummel RC, Ainsworth E, Hobert M, Streffer J, Berg D, Chiari L. PLoS One. 2012;7(3):e32240. Epub 2012 Mar 23.
Neuroimaging: Current role in detecting pre-motor Parkinson's disease.
Godau J, Hussl A, Lolekha P, Stoessl AJ, Seppi K. Mov Disord. 2012 Apr 15;27(5):634-43. doi: 10.1002/mds.24976.
Can we define "pre-motor" Parkinson's disease?
Berg D, Poewe W. Mov Disord. 2012 Apr 15;27(5):595-6. doi: 10.1002/mds.24995.
Repeatable target localization for long-term in vivo imaging of mice with 2-photon microscopy.
Hefendehl JK, Milford D, Eicke D, Wegenast-Braun BM, Calhoun ME, Grathwohl SA, Jucker M, Liebig C. J Neurosci Methods. 2012 Apr 15;205(2):357-63. Epub 2011 Nov 6.
Motor signs in the prodromal phase of Parkinson's disease.
Maetzler W, Hausdorff JM. Mov Disord. 2012 Apr 15;27(5):627-33. doi: 10.1002/mds.24973. Epub 2012 Mar 21.
The amyloid state of proteins in human diseases.
Eisenberg D, Jucker M. Cell. 2012 Mar 16;148(6):1188-203.
Predictive value and reward in implicit classification learning.
Lam JM, Wächter T, Globas C, Karnath HO, Luft AR. Hum Brain Mapp. 2012 Mar 15. doi: 10.1002/hbm.21431. [Epub ahead of print]
Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.
Simón-Sánchez J, Kilarski LL, Nalls MA, Martinez M, Schulte C, Holmans P; International Parkinson's Disease Genomics Consortium; Wellcome Trust Case Control Consortium, Gasser T, Hardy J, Singleton AB, Wood NW, Brice A, Heutink P, Williams N, Morris HR. PLoS One. 2012;7(3):e28787. Epub 2012 Mar 12.
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database.
Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, Destefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP; 23andMe, The Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium; The International Parkinson's Disease Genomics Consortium (IPDGC); The Parkinson's Disease GWAS Consortium; The Wellcome Trust Case Control Consortium 2 (WTCCC2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L. PLoS Genet. 2012 Mar;8(3):e1002548. Epub 2012 Mar 15.
Weighting models and weighting factors.
G Vosgerau, M Synofzik; Conscious Cogn. 2012 Mar;21(1):55-8. Epub 2011 Oct 24.
The valence of action outcomes modulates the perception of one's actions.
C Wilke, M Synofzik, A Lindner; Conscious Cogn. 2012 Mar;21(1):18-29. Epub 2011 Jul 14.
Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.
RF Rosen, JJ Fritz, J Dooyema, AF Cintron, T Hamaguchi, JJ Lah, H Levine 3rd, M Jucker, LC Walker; J Neurochem. 2012 Mar;120(5):660-666. doi: 10.1111/j.1471-4159.2011.07551.x. Epub 2011 Nov 18.
Beyond the comparator model.
Synofzik M, Vosgerau G. Conscious Cogn. 2012 Mar;21(1):1-3. Epub 2012 Feb 1.
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
Schmid SP, Schleicher ED, Cegan A, Deuschle C, Baur S, Hauser AK, Synofzik M, Srulijes K, Brockmann K, Berg D, Maetzler W. Mov Disord. 2012 Feb;27(2):288-93. doi: 10.1002/mds.23984. Epub 2011 Oct 21.
Phosphorylated α-Synuclein in Parkinson's Disease.
Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J. Sci Transl Med. 2012 Feb 15;4(121):121ra20.
Viral and inflammatory triggers of neurodegenerative diseases.
Deleidi M, Isacson O. Sci Transl Med. 2012 Feb 15;4(121):121ps3.
Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function.
JC Fitzgerald, MD Camprubi, L Dunn, HC Wu, NY Ip, R Kruger, LM Martins, NW Wood, H Plun-Favreau; Cell Death Differ. 2012 Feb;19(2):257-66. doi: 10.1038/cdd.2011.90. Epub 2011 Jun 24.
Is pre-motor diagnosis possible?--The European experience.
Berg D. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S195-8.
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.
Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stöffler A, Streffer J, Berg D. J Neural Transm. 2012 Jan;119(1):39-52. Epub 2011 Jul 14.
Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.
Liepelt-Scarfone I, Jamour M, Maetzler W. Z Gerontol Geriatr. 2012 Jan;45(1):23-33.
Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Srulijes K, Reimold M, Liscic RM, Bauer S, Dietzel E, Liepelt-Scarfone I, Berg D, Maetzler W. Mov Disord. 2012 Jan;27(1):151-5.
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain.
T Hamaguchi, YS Eisele, NH Varvel, BT Lamb, LC Walker, M Jucker; Acta Neuropathol. 2012 Jan;123(1):31-7. Epub 2011 Nov 20.
Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimer΄s Disease.
G Straten, R Saur, C Laske, T Gasser, P Annas, H Basun, T Leyhe; Curr Alzheimer Res. 2011 Dec 1;8(8):853-9.
Vagus nerve somatosensory evoked potentials in Parkinson's disease.
T Polak, D Weise, F Metzger, AC Ehlis, JB Langer, A Schramm, AJ Fallgatter, J Classen; J Neurol. 2011 Dec;258(12):2276-7. Epub 2011 May 11.
Early onset amyloid lesions lead to severe neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice
NJ Rupp, BM Wegenast-Braun, R Radde, ME Calhoun, M Jucker; Neurobiol Aging. 2011 Dec;32(12):2324.e1-6. Epub 2010 Oct 22.
Poor Trail Making Test Performance Is Directly Associated with Altered Dual Task Prioritization in the Elderly - Baseline Results from the TREND Study.
MA Hobert, R Niebler, SI Meyer, K Brockmann, C Becker, H Huber, A Gaenslen, J Godau, GW Eschweiler, D Berg, W Maetzler; PLoS One. 2011;6(11):e27831. Epub 2011 Nov 16.
BRI2 Protein Regulates {beta}-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE).
E Kilger, A Buehler, H Woelfing, S Kumar, SA Kaeser, A Nagarathinam, J Walter, M Jucker, J Coomaraswamy;J Biol Chem. 2011 Oct 28;286(43):37446-57. Epub 2011 Aug 26.
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
SP Schmid, ED Schleicher, A Cegan, C Deuschle, S Baur, AK Hauser, M Synofzik, K Srulijes, K Brockmann, D Berg, W Maetzler; Mov Disord. 2011 Oct 21. doi: 10.1002/mds.23984. [Epub ahead of print]
Soluble A{beta} Seeds Are Potent Inducers of Cerebral {beta}-Amyloid Deposition.
F Langer, YS Eisele, SK Fritschi, M Staufenbiel, LC Walker, M Jucker; J Neurosci. 2011 Oct 12;31(41):14488-14495.
open PubMed Abstract
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.
K Brockmann, A Gröger, A Di Santo, I Liepelt, C Schulte, U Klose, W Maetzler, AK Hauser, R Hilker, B Gomez-Mancilla, D Berg, T Gasser;Mov Disord. 2011 Oct 11. doi: 10.1002/mds.23991. [Epub ahead of print]
open PubMed Abstract
Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.
MB Hartig, A Iuso, T Haack, T Kmiec, E Jurkiewicz, K Heim, S Roeber, V Tarabin, S Dusi, M Krajewska-Walasek, S Jozwiak, M Hempel, J Winkelmann, M Elstner, K Oexle, T Klopstock, W Mueller-Felber, T Gasser, C Trenkwalder, V Tiranti, H Kretzschmar, G Schmitz, TM Strom, T Meitinger, H Prokisch; Am J Hum Genet. 2011 Oct 7;89(4):543-50.
open PubMed Abstract
Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe
J Schicks, M Synofzik, C Beetz, F Schiele, L Schöls; Clinical Genetics, 80: 503–504. Article first published online: 5 OCT 2011. doi: 10.1111/j.1399-0004.2011.01651.x
Neuropathology in mice expressing mouse alpha-synuclein
C Rieker, KK Dev, K Lehnhoff, S Barbieri, I Ksiazek, S Kauffmann, S Danner, H Schell, C Boden, MA Ruegg, PJ Kahle, H van der Putten, DR Shimshek; PLoS One. 2011;6(9):e24834. Epub 2011 Sep 26.
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease
M Sharma, DM Maraganore, JPA Ioannidis, O Riess, JO Aasly, G Annesi, N Abahuni, AR Bentivoglio, A Brice, C Van Broeckhoven, M-C Chartier-Harlin, A Destée, A Djarmati, A Elbaz, M Farrer, C Ferrarese, JM Gibson, S Gispert, N Hattori, B Jasinska-Myga, C Klein, S Lesage, T Lynch, P Lichtner, J-C Lambert, AE Lang, GD Mellick, F De Nigris, G Opala, A Quattrone, C Riva, E Rogaeva, OA Ross, W Satake, PA Silburn, J Theuns, T Toda, H Tomiyama, RJ Uitti, K Wirdefeldt, Z Wszolek, T Gasser, R Krüger; Neurobiol Aging. 2011 Nov;32(11):2108.e1-5. Epub 2011 Jul 22.
Rapid emergence of temporal and pulvinar lesions in MELAS mimicking Creutzfeldt-Jakob disease.
D Weiss, K Brockmann, T Nägele, T Gasser, R Krüger; Neurology. 2011 Aug 30;77(9):914.
Tissue specific resonance frequencies of water and metabolites within the human brain
GL Chadzynski, B Bender, A Groeger, M Erb, U Klose; J Magn Reson. 2011 Sep;212(1):55-63. Epub 2011 Jul 12.
open PubMed Abstract
Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation
M Synofzik, J Schicks, T Lindig, S Biskup, T Schmidt, J Hansel, F Lehmann-Horn, L Schöls; J Med Genet. 2011 Oct;48(10):713-5. Epub 2011 Jul 11.
Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages
S Nuber, E Petrasch-Parwez, O Arias-Carrión, L Koch, Z Kohl, J Schneider, C Calaminus, R Dermietzel, A Samarina, J Boy, HP Nguyen, P Teismann, TP Velavan, PJ Kahle, S von Hörsten, M Fendt, R Krüger, O Riess; Neurobiol Dis. 2011 Nov;44(2):192-204. Epub 2011 Jul 5.
Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease
I Liepelt-Scarfone, S Graeber, A Feseker, G Baysal, J Godau, A Gaenslen, W Maetzler, B Berg; Parkinsons Dis. 2011;2011:540843. Epub 2011 May 23.
Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of lewy body-associated dementias
W Maetzler, D Berg, M Synofzik, K Brockmann, J Godau, A Melms, T Gasser, S Hörnig, M Langkamp; J Alzheimers Dis. 2011;26(1):171-9.
Stem cell factor plasma levels are decreased in alzheimer's disease patients with fast cognitive decline after one-year follow-up period: The pythia-study
C Laske, K Sopova, N Hoffmann, E Stransky, K Hagen, AJ Fallgatter, K Stellos, T Leyhe; J Alzheimers Dis. 2011;26(1):39-45.
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, JA Bacon, S Bardien, M Bozi, A Brice, L Brighina, C Van Broeckhoven, J Carr, MC Chartier-Harlin, E Dardiotis, DW Dickson, NN Diehl, A Elbaz, C Ferrarese, A Ferraris, B Fiske, JM Gibson, R Gibson, GM Hadjigeorgiou, N Hattori, JP Ioannidis, B Jasinska-Myga, BS Jeon, YJ Kim, C Klein, R Kruger, E Kyratzi, S Lesage, CH Lin, T Lynch, DM Maraganore, GD Mellick, E Mutez, C Nilsson, G Opala, SS Park, A Puschmann, A Quattrone, M Sharma, PA Silburn, YH Sohn, L Stefanis, V Tadic, J Theuns, H Tomiyama, RJ Uitti, EM Valente, S van de Loo, DK Vassilatis, C Vilariño-Güell, LR White, K Wirdefeldt, ZK Wszolek, R-M Wu, MJ Farrer; Lancet Neurol. 2011 Oct;10(10):898-908. Epub 2011 Aug 30.
TDP-43 and FUS/TLS: Cellular functions and implications for neurodegeneration
FC Fiesel, PJ Kahle; FEBS J. 2011 Oct;278(19):3550-68. doi: 10.1111/j.1742-4658.2011.08258.x. Epub 2011 Aug 24.
Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.
LF Burbulla, R Krüger; J Neurol Sci. 2011 Jul 15;306(1-2):1-8. Epub 2011 Apr 21.
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
GU Höglinger, NM Melhem, DW Dickson, PM Sleiman, LS Wang, L Klei, R Rademakers, R de Silva, I Litvan, DE Riley, JC van Swieten, P Heutink, ZK Wszolek, RJ Uitti, J Vandrovcova, HI Hurtig, RG Gross, W Maetzler, S Goldwurm, E Tolosa, B Borroni, P Pastor; PSP Genetics Study Group, RL Albin, E Alonso, A Antonini, M Apfelbacher, SE Arnold, J Avila, TG Beach, S Beecher, D Berg, TD Bird, N Bogdanovic, AJ Boon, Y Bordelon, A Brice, H Budka, M Canesi, WZ Chiu, R Cilia, C Colosimo, PP De Deyn, JG de Yebenes, LD Kaat, R Duara, A Durr, S Engelborghs, G Fabbrini, NA Finch, R Flook, MP Frosch, C Gaig, DR Galasko, T Gasser, M Gearing, ET Geller, B Ghetti, NR Graff-Radford, M Grossman, DA Hall, LN Hazrati, M Höllerhage, J Jankovic, JL Juncos, A Karydas, HA Kretzschmar, I Leber, VM Lee, AP Lieberman, KE Lyons, C Mariani, E Masliah, LA Massey, CA McLean, N Meucci, BL Miller, B Mollenhauer, JC Möller, HR Morris, C Morris, SS O'Sullivan, WH Oertel, D Ottaviani, A Padovani, R Pahwa, G Pezzoli, S Pickering-Brown, W Poewe, A Rabano, A Rajput, SG Reich, G Respondek, S Roeber, JD Rohrer, OA Ross, MN Rossor, G Sacilotto, WW Seeley, K Seppi, L Silveira-Moriyama, S Spina, K Srulijes, P St George-Hyslop, M Stamelou, DG Standaert, S Tesei, WW Tourtellotte, C Trenkwalder, C Troakes, JQ Trojanowski, JC Troncoso, VM Van Deerlin, JP Vonsattel, GK Wenning, CL White, P Winter, C Zarow, AL Zecchinelli, LB Cantwell, MR Han, A Dillman, MP van der Brug, JR Gibbs, MR Cookson, DG Hernandez, AB Singleton, MJ Farrer, CE Yu, LI Golbe, T Revesz, J Hardy, AJ Lees, B Devlin, H Hakonarson, U Müller, GD Schellenberg; Nat Genet. 2011 Jun 19;43(7):699-705. doi: 10.1038/ng.859.
AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials.
D Berg, J Godau, C Trenkwalder, K Eggert, I Csoti, A Storch, H Huber, M Morelli-Canelo, M Stamelou, V Ries, M Wolz, C Schneider, T Di Paolo, F Gasparini, S Hariry, M Vandemeulebroecke, W Abi-Saab, K Cooke, D Johns, B Gomez-Mancilla; Mov Disord. 2011 Jun;26(7):1243-50. doi: 10.1002/mds.23616. Epub 2011 Apr 11.
Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features.
Synofzik M, Beetz C, Bauer C, Bonin M, Sanchez-Ferrero E, Schmitz-Hübsch T, Wüllner U, Nägele T, Riess O, Schöls L, Bauer P, J Med Genet. 2011 Jun;48(6):407-12. Epub 2011 Mar 1.
Milestones in PD genetics.
Gasser T, Hardy J, Mizuno Y, Mov Disord. 2011 May;26(6):1042-8. doi: 10.1002/mds.23637.
Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.
Berg D, Steinberger JD, Warren Olanow C, Naidich TP, Yousry TA, Mov Disord. 2011 May;26(6):979-92. doi: 10.1002/mds.23766.
Central oscillators in a patient with neuropathic tremor: Evidence from intraoperative local field potential recordings
Weiss D, Govindan RB, Rilk A, Wächter T, Breit S, Zizlsperger L, Haarmeier T, Plewnia C, Krüger R, Gharabaghi A., Mov Disord. 2011 Feb 1;26(2):323-7.
Relation of risk factors and putative premotor markers for Parkinson's disease.
Liepelt-Scarfone I, Behnke S, Godau J, Schweitzer KJ, Wolf B, Gaenslen A, Berg D, J Neural Transm. 2011 Apr;118(4):579-85. Epub 2011 Jan 6.
Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans.
C Roder, V Peters, H Kasuya, T Nishizawa, Y Takehara, D Berg, C Schulte, N Khan, M Tatagiba, B Krischek; Childs Nerv Syst. 2011 Feb;Epub 2010 Aug 6.
Serum and Cerebrospinal Fluid Uric Acid Levels in Lewy Body Disorders: Associations with Disease Occurrence and Amyloid-β Pathway.
W Maetzler, AK Stapf, C Schulte, AK Hauser, S Lerche, I Wurster, E Schleicher, A Melms, D Berg; J Alzheimers Dis. 2011 Jan 1;27(1):119-26.
A tool to improve pre-selection for deep brain stimulation in patients with Parkinson's disease.
T Wächter, A Mínguez-Castellanos, F Valldeoriola, J Herzog, H Stoevelaar; J Neurol. 2010 Nov 19. [Epub ahead of print]
POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe.
J. Schicks, M. Synofzik, C. Schulte, L. Schöls, Mov Disord. 2010 Nov 15;25(15):2678-82.
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: Functional impact of disease-related variants on mitochondrial homeostasis.
LF Burbulla, C Schelling, H Kato, D Rapaport, D Woitalla, C Schiesling, C Schulte, M Sharma, T Illig, P Bauer, S Jung, A Nordheim, L Schöls, O Riess, R Krüger; Hum Mol Genet. 2010 Nov 15;19(22):4437-52. Epub 2010 Sep 2.
Microglia activation is related to substantia nigra echogenicity.
D. Berg, J. Godau, P. Riederer, M. Gerlach, T. Arzberger, J Neural Transm. 2010 Nov;117(11):1287-92. Epub 2010 Nov 6.
Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.
P Bauer, G Stevanin, C Beetz, M Synofzik, T Schmitz-Hübsch, U Wüllner, E Berthier, E Ollagnon-Roman, O Riess, S Forlani, E Mundwiller, A Durr, L Schöls, A Brice; J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1229-32. Epub 2010 Jul 28.
Transcranial sonography in movement disorders. Conclusions.
D Berg; Int Rev Neurobiol. 2010;90:287-9.
Balance is the challenge - The impact of mitochondrial dynamics in Parkinson's disease.
LF Burbulla, G Krebiehl, R Krüger; Eur J Clin Invest. 2010 Nov.
Complex hyperkinetic movement disorders associated with POLG mutations.
M. Synofzik, R. Schüle, C. Schulte, R. Krüger, T. Lindig, L. Schöls, F. Asmus, Mov Disord. 2010 Oct 30;25(14):2472-5.
ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2.
K Haebig, CJ Gloeckner, MG Miralles, F Gillardon, C Schulte, O Riess, M Ueffing, S Biskup, M Bonin; PLoS One. 2010 Oct 29.
Early onset amyloid lesions lead to servere neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice.
NJ Rupp, BM Wegenast-Braun, R Radde, ME Calhoun, M Jucker; Neurobiol Aging. 2010 Oct 21. [Epub ahead of print]
Peripherally Applied A{beta}-Containing Inoculates Induce Cerebral {beta}-Amyloidosis.
YS Eisele, U Obermüller, G Heilbronner, F Baumann, SA Kaeser, H Wolburg, LC Walker, M Staufenbiel, M Heikenwalder, M Jucker; Science. 2010 Oct 21. [Epub ahead of print]
Analysis of ACTA2 in European Moyamoya disease patients.
C Roder, V Peters, H Kasuya, T Nishizawa, S Wakita, D Berg, C Schulte, N Khan, M Tatagiba, B Krischek; Eur J Paediatr Neurol. 2010 Oct 20. [Epub ahead of print]
A large genome scan for rare CNVs in amyotrophic lateral sclerosis.
HM Blauw, A Al-Chalabi, PM Andersen, PW van Vught, FP Diekstra, MA van Es, CG Saris, EJ Groen, W van Rheenen, M Koppers, Rv Slot, E Strengman, K Estrada, F Rivadeneira, A Hofman, AG Uitterlinden, LA Kiemeney, SH Vermeulen, A Birve, S Waibel, T Meyer, S Cronin, RL McLaughlin, O hardiman, PC Sapp, MD Tobin, LV Wain, B Tomik, A Slowik, R Lemmens, D Rujescu, C Schulte, T Gasser, RH Brown Jr., JE Landers, W Robberecht, AC Ludolph, RA Ophoff, JH Veldink, LH van den Berg; Hum Mol Genet. 2010 Oct 15;Epub 2010 Aug 4.
A polymorphism in the gene encoding AdipoR1 affects olfactory recognition.
M Guthoff, O Tschritter, D Berg, I Liepelt, C Schulte, F Machicao, H Breer, H-U Haering, A Fritsche; Int J Obes (Lond). 2010 Oct 12.
The benefits and limitations of animal models for translational research in neurodegenerative diseases.
M. Jucker, Nat Med. 2010 Nov;16(11):1210-4. Epub 2010 Sep 21.
Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.
D Berg; J Neural Transm. 2010 Sep 10.
TDP-43-mediated neuron loss In Vivo requires RNA-binding activity.
A Voigt, D Herholz, FC Fiesel, K Kaur, D Müller, P Karsten, SS Weber, PJ Kahle, T Marquardt, JB Schulz; PloS One. 2010 Aug 18.
Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy.
S. Nicolai, A. Mirelman, T. Herman, A. Zijlstra, M. Mancini, C. Becker, U. Lindemann, D. Berg, W. Maetzler, Z Gerontol Geriatr. 2010 Aug;43(4):224-8
Place value of transcranial sonography in early diagnosis of Parkinson's disease.
D. Berg, A. Gaenslen, Neurodegener Dis. 2010;7(5):291-9. Epub 2010 Jul 9.
Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.
Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B., Acta Neurochir (Wien). 2010 Dec;152(12):2153-60. Epub 2010 Jun 23.
Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities.
D. Weiss, T. Wächter, S. Breit, SN Jacob, JK Pomper, F. Asmus, J. Valls-Solé, C. Plewnia, T. Gasser, A. Gharabaghi, R. Krüger, J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1002-7. Epub 2010 Jun 20.
Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice.
W. Maetzler, D. Berg, C. Funke, F. Sandmann, H. Stünitz, C. Maetzler, C. Nitsch, Am J Pathol. 2010 Aug;177(2):829-39. Epub 2010 Jun 3.
Severe orthostatic dysregulation associated with Wolfram syndrome.
M. Synofzik, D. Weiss, J. Erharhaghen, R. Krüger, L. Schöls, J Neurol. 2010 Oct;257(10):1751-3. Epub 2010 May 19.
A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42).
NA Schlipf, C. Beetz, R. Schüle, G. Stevanin, AK Erichsen, S. Forlani, C. Zaros, K. Karle, S. Klebe, S. Klimpe, A. Durr, S. Otto, CM Tallaksen, O. Riess, A. Brice, P. Bauer, L. Schöls, Eur J Hum Genet. 2010 Sep;18(9):1065-7. Epub 2010 May 12.
Expression profiling in peripheral blood reveals signature for penetrance in DYT1 dystonia.
M Walter, M Bonin, RS Pullman, EM Valente, M Loi, M Gambarin, D Raymond, M Tinazzi, C Kamm, N Glöckle, S Poths, T Gasser, SB Bressman, C Klein, LJ Ozelius, O Riess, K Grundmann; Neurobiol Dis. 2010 May, Epub 2010 Jan 4.
Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.
J Coomaraswamy, E Kilger, H Wölfing, C Schäfer, SA Kaeser, BM Wegenast-Braun, JK Hefendehl, H Wolburg, M Mazzella, J Ghiso, M Goedert, H Akiyama, F Garcia-Sierra, DP Wolfer, PM Mathews, M Jucker; Proc Natl Acad Sci U S A. 2010 Apr 27; 107(17): 7969-74. Epub 2010 Apr 12.
Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
W Maetzler, V Stoycheva, B Schmid, C Schulte, AK Hauser, K Brockmann, A Melms, T Gasser, D Berg; J Alzheimers Dis. 2010 Jan 1;22(3):933-8.
Identifying PD-causing genes and genetic susceptibility factors: Current approaches and future prospects.
T Gasser; Prog Brain Res. 2010
Transcranial sonography in the premotor diagnosis of Parkinson's disease.
S Behnke, U Schröder, D Berg; Int Rev Neurobiol. 2010
Transcranial sonography in restless legs syndrome.
J Godau, M Sojer; Int Rev Neurobiol. 2010
Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical Parkinsonian syndromes.
AEP Bouwmans, AMM Vlaar, K Srulijes, WH Mess, WEJ Weber; Int Rev Neurobiol. 2010.
Early diagnosis of Parkinson's disease.
A Gaenslen, D Berg; Int Rev Neurobiol. 2010.
Transcranial sonography in dystonia.
A Gaenslen; Int Rev Neurobiol. 2010
Transcranial sonography-anatomy
H Huber; Int Rev Neurobiol. 2010.
TCS in monogenic forms of Parkinson's disease
K Brockmann, J Hagenah; Int Rev Neurobiol. 2010.
Genome-wide association study reveals genetic risk underlying Parkinson's disease.
J Simón-Sánchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, C Paisan-Ruiz, P Lichtner, SW Scholz, DG Hernandez, R Krüger, M Federoff, C Klein, A Goate, J Perlmutter, M Bonin, MA Nalls, T Illig, C Gieger, H Houlden, M Steffens, MS Okun, BA Racette, MR Cookson, KD Foote, HH Fernandez, BJ Traynor, S Schreiber, S Arepalli, R Zonozi, K Gwinn, M van der Brug, G Lopez, SJ Chanock, A Schatzkin, Y Park, A Hollenbeck, J Gao, X Huang, NW Wood, D Lorenz, G Deuschl, H Chen, O Riess, JA Hardy, AB Singleton, T Gasser; Nat Genet. 2009 Dec; 41(12): 1308-12. Epub 2009 Nov 15.
Formation and maintenance of Alzheimer’s disease β-amyloid plaques in the absence of microglia
SA Grathwohl, RE Kälin, T Bolmont, S Prokop, G Winkelmann, SA Kaeser, J Odenthal, R Radde, T Eldh, S Gandy, A Aguzzi, M Staufenbiel, PM Mathews, H Wolburg, FL Heppner, M Jucker; Nat Neurosci. 2009 Nov; 12(11): 1361-3. Epub 2009 Oct 18.
Induction of cerebral beta-amyloidosis: Intracerebral versus systemic Abeta inoculation.
Y. S. Eisele, T Bolmont, M Heikenwalder, F Langer, L. H. Jacobson, Z.-X. Yan, K Roth, A Aguzzi, M Staufenbiel, L. C. Walker, M Jucker; Proc Natl Acad Sci U S A, 2009 Aug 4;106(31):12926-31. Epub 2009 Jul 21.